Microbial dysbiosis in bronchiectasis

被引：7

作者：

Hurst, John R. ^{[1
]}

机构：

[1] UCL, UCL Resp Med, London NW3 2PF, England

来源：

LANCET RESPIRATORY MEDICINE | 2014年 / 2卷 / 12期

关键词：

CYSTIC FIBROSIS BRONCHIECTASIS; RANDOMIZED CONTROLLED-TRIAL; EXACERBATIONS; AZITHROMYCIN; PREVENTION;

D O I：

10.1016/S2213-2600(14)70223-1

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：945 / 947

页数：3

共 9 条

[1] Azithromycin for Prevention of Exacerbations of COPD [J].

Albert, Richard K. ;

Connett, John ;

Bailey, William C. ;

Casaburi, Richard ;

Cooper, J. Allen D., Jr. ;

Criner, Gerard J. ;

Curtis, Jeffrey L. ;

Dransfield, Mark T. ;

Han, MeiLan K. ;

Lazarus, Stephen C. ;

Make, Barry ;

Marchetti, Nathaniel ;

Martinez, Fernando J. ;

Madinger, Nancy E. ;

McEvoy, Charlene ;

Niewoehner, Dennis E. ;

Porsasz, Janos ;

Price, Connie S. ;

Reilly, John ;

Scanlon, Paul D. ;

Sciurba, Frank C. ;

Scharf, Steven M. ;

Washko, George R. ;

Woodruff, Prescott G. ;

Anthonisen, Nicholas R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :689-698

[2] Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial [J].

Altenburg, Josje ;

de Graaff, Casper S. ;

Stienstra, Ymkje ;

Sloos, Jacobus H. ;

van Haren, Eric H. J. ;

Koppers, Ralph J. H. ;

van der Werf, Tjip S. ;

Boersma, Wim G. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12) :1251-1259

[3] AN ORDINATION OF THE UPLAND FOREST COMMUNITIES OF SOUTHERN WISCONSIN [J].

BRAY, JR ;

CURTIS, JT .

ECOLOGICAL MONOGRAPHS, 1957, 27 (04) :326-349

[4] Microbiome science needs a healthy dose of scepticism [J].

Hanage, William P. .

NATURE, 2014, 512 (7514) :247-248

[5] Disordered Microbial Communities in Asthmatic Airways [J].

Hilty, Markus ;

Burke, Conor ;

Pedro, Helder ;

Cardenas, Paul ;

Bush, Andy ;

Bossley, Cara ;

Davies, Jane ;

Ervine, Aaron ;

Poulter, Len ;

Pachter, Lior ;

Moffatt, Miriam F. ;

Cookson, William O. C. .

PLOS ONE, 2010, 5 (01)

[6]

Rogers GB., 2014, The Lancet Respiratory Medicine

[7] Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases [J].

Serisier, David J. .

LANCET RESPIRATORY MEDICINE, 2013, 1 (03) :262-274

[8] Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial [J].

Serisier, David J. ;

Martin, Megan L. ;

McGuckin, Michael A. ;

Lourie, Rohan ;

Chen, Alice C. ;

Brain, Barbara ;

Biga, Sally ;

Schlebusch, Sanmarie ;

Dash, Peter ;

Bowler, Simon D. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12) :1260-1267

[9] Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial [J].

Wong, Conroy ;

Jayaram, Lata ;

Karalus, Noel ;

Eaton, Tam ;

Tong, Cecilia ;

Hockey, Hans ;

Milne, David ;

Fergusson, Wendy ;

Tuffery, Christine ;

Sexton, Paul ;

Storey, Louanne ;

Ashton, Toni .

LANCET, 2012, 380 (9842) :660-667

← 1 →